Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [1] Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
    Molina-Infante, Javier
    Pazos-Pacheco, Carmen
    Vinagre-Rodriguez, Gema
    Perez-Gallardo, Belen
    Duenas-Sadornil, Carmen
    Hernandez-Alonso, Moises
    Gonzalez-Garcia, Guadalupe
    Mateos-Rodriguez, Jose M.
    Fernandez-Bermejo, Miguel
    Gisbert, Javier P.
    HELICOBACTER, 2012, 17 (04) : 269 - 276
  • [2] Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting
    Dolapcioglu, Can
    Koc-Yesiltoprak, Aysun
    Ahishali, Emel
    Kural, Aziz
    Dolapcioglu, Hatice
    Soylu, Aliye
    Dabak, Resat
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (08): : 2324 - 2328
  • [3] Sequential Versus Triple Standard Therapy for Helicobacter pylori Eradication
    Yep-Gamarra, Victor
    Rodriguez-Ulloa, Carlos
    Diaz-Velez, Cristian
    Aldave-Herrera, Augusto
    Donet, Jean A.
    Rodas, Jonny I.
    Calvo, Hector
    Cardena, Rakel E.
    Vasquez-Tirado, Gustavo
    Rojas-Vera, Jorge
    GASTROENTEROLOGY, 2013, 144 (05) : S333 - S333
  • [4] Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    Satoshi Hoshiya
    Kazuhiro Watanabe
    Kengo Tokunaga
    Akifumi Tanaka
    Hidehiko Ninomiya
    Masao Shingaki
    Takeshi Itoh
    Shozo Saito
    Hitoshi Ishida
    Shin'ichi Takahashi
    Journal of Gastroenterology, 2000, 35 (1) : 10 - 14
  • [5] Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    Hoshiya, S
    Watanabe, K
    Tokunaga, K
    Tanaka, A
    Ninomiya, H
    Shingaki, M
    Itoh, T
    Saito, S
    Ishida, H
    Takahashi, S
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) : 10 - 14
  • [6] Evaluation of the eradication effect for Helicobacter pylori against clarithromycin-sensitive strains and clarithromycin-resistant strains in triple therapy with rabeprazole, amoxicillin, and clarithromycin:: Randomized comparison with triple therapy using lansoprazole
    Murakami, K
    Nasu, M
    Fujioka, T
    Sato, R
    Okimoto, T
    Kodama, M
    Kagawa, J
    GUT, 2002, 51 : A99 - A99
  • [7] Clarithromycin-Resistant Genotypes and Eradication of Helicobacter Pylori
    Francavilla, Ruggiero
    Lionetti, Elena
    Castellaneta, Stefania
    Margiotta, Marcella
    Piscitelli, Domenico
    Lorenzo, Lorenzo
    Cavallo, Luciano
    Ierardi, Enzo
    JOURNAL OF PEDIATRICS, 2010, 157 (02): : 228 - 232
  • [8] The recurrence and clarithromycin-resistant rate of Helicobacter pylori after eradication therapy in Japan
    Okimoto, T.
    Kodama, M.
    Murakami, K.
    Fujioka, T.
    HELICOBACTER, 2007, 12 (04) : 449 - 449
  • [9] EFFICACY OF HELICOBACTER PYLORI ERADICATION WITH DUAL AND QUADRUPLE THERAPY IN THE CLARITHROMYCIN-RESISTANT PATIENTS
    Moon, J.
    Lee, J.
    Seong, H.
    Song, P.
    Yoon, W.
    Ryu, S.
    Kim, Y.
    Seol, S.
    HELICOBACTER, 2015, 20 : 104 - 104
  • [10] Clarithromycin-resistant genotypes and eradication of Helicobacter pylori
    De Francesco, V
    Margiotta, M
    Zullo, A
    Hassan, C
    Trolani, L
    Burattini, O
    Stella, F
    Di Leo, A
    Russo, F
    Marangi, S
    Monno, R
    Stoppino, V
    Morini, S
    Panella, C
    Ierardi, E
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (02) : 94 - 100